{"issuance_frequency":"","notes_translated":{"fr":"Selon le Réglement sur les aliments et les drogues, alinéa C.01.014 il est interdit au fabricant de vendre un médicament sous forme posologique à moins qu'une identification numérique de drogue (DIN) n'ait été assignée au produit et que ce DIN n'ait pas été annulé selon l'alinéa C.01.014.6. Dans le cas de drogues nouvelles, une présentation de drogue nouvelle soumise tel que requis au Titre 8 des Règlements sur les aliments et drogues sera considérée comme une demande d'identification numérique de drogue. Lorsqu'un produit n'est pas considéré comme drogue nouvelle on réfère à la demande comme demande d'identification numérique de drogue.","en":"(DIN) has been assigned for that drug and the assignment of the number has not been cancelled pursuant to section C.01.014.6. In the case of a new drug, a new drug submission filed pursuant to Division 8 of the Food and Drug Regulations is regarded as an application for a DIN. When a product is not subject to Division 8, the application is called a DIN submission."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"dc5fc8f1-9d3b-495d-ae2d-6d62bd4acc19","metadata_created":"2021-07-06T15:41:29.244563","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-06T15:41:29.244569","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-06","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Ligne directrice","numéro d'identification du médicament","DIN","préparation des présentations de DIN","article C.01.014","Règlement sur les aliments et drogues","article C.01.014.6.","une nouvelle drogue","une nouvelle présentation de drogue","une demande de DIN"],"en":["Guideline","drug identification number","DIN","preparation of DIN Submissions","ssection C.01.014","Food and Drug Regulations","section C.01.014.6.","a new drug","a new drug submission","an application for a DIN"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Directive de la direction des médicaments","en":"Guideline on Preparation of DIN Submissions"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"dc5fc8f1-9d3b-495d-ae2d-6d62bd4acc19","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1b9818be-0b44-4f9b-bb99-2114925cecfe","related_relationship":"","name_translated":{"fr":"Directive de la direction des médicaments","en":"Guideline on Preparation of DIN Submissions"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guideline on Preparation of DIN Submissions","language":["en"],"created":"2021-07-06T15:41:29.338986","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/preparation-drug-identification-number-submissions.html#Introduction","last_modified":null,"position":0,"revision_id":"509e5dd4-44bf-4ae4-b55a-ab274708929c","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"dc5fc8f1-9d3b-495d-ae2d-6d62bd4acc19","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"170df06c-7d87-490a-9497-e2acca773ebe","related_relationship":"","name_translated":{"fr":"Directive de la direction des médicaments","en":"Guideline on Preparation of DIN Submissions"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guideline on Preparation of DIN Submissions","language":["fr"],"created":"2021-07-06T15:41:29.338991","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/presentation-demandes-identification-numerique-drogue.html#Introduction","last_modified":null,"position":1,"revision_id":"509e5dd4-44bf-4ae4-b55a-ab274708929c","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2009-08-26 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"dc5fc8f1-9d3b-495d-ae2d-6d62bd4acc19","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"(DIN) has been assigned for that drug and the assignment of the number has not been cancelled pursuant to section C.01.014.6. In the case of a new drug, a new drug submission filed pursuant to Division 8 of the Food and Drug Regulations is regarded as an application for a DIN. When a product is not subject to Division 8, the application is called a DIN submission.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guideline on Preparation of DIN Submissions","revision_id":"509e5dd4-44bf-4ae4-b55a-ab274708929c"}